April 14, 2020
Partnering with a leading pharmaceutical company in their quest to identify novel biomarkers of RA for therapeutic targeting, we set out to satisfy their restrictive study design criteria.
Partnering with a leading pharmaceutical company in their quest to identify novel biomarkers of RA for therapeutic targeting, we set out to satisfy their restrictive study design criteria.